ChemoCentryx, Inc.
CCXI · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $2,392 | $4,067 | $2,250 | $543 |
| - Cash | $50 | $32 | $39 | $28 |
| + Debt | $5 | $25 | $21 | $169 |
| Enterprise Value | $2,346 | $4,060 | $2,232 | $684 |
| Revenue | $32 | $65 | $36 | $43 |
| % Growth | -50.3% | 80.5% | -16.1% | – |
| Gross Profit | $32 | $65 | $36 | $43 |
| % Margin | 99.1% | 100% | 100% | 100% |
| EBITDA | -$131 | -$52 | -$52 | -$36 |
| % Margin | -407.5% | -80% | -143.8% | -84.5% |
| Net Income | -$129 | -$55 | -$55 | -$38 |
| % Margin | -400.5% | -85.3% | -154.3% | -88.6% |
| EPS Diluted | -1.96 | -0.84 | -0.98 | -0.76 |
| % Growth | -133.3% | 14.3% | -28.9% | – |
| Operating Cash Flow | -$76 | -$81 | -$70 | $16 |
| Capital Expenditures | -$19 | -$15 | -$1 | -$1 |
| Free Cash Flow | -$95 | -$97 | -$71 | $16 |